Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction

(1) Background: Soluble urokinase-type plasminogen activator receptor (suPAR) has been implicated in the pathogenesis of kidney disease in different disease settings. The aim of this study was to investigate a possible link between suPAR circulating levels and renal impairment (RI) in newly diagnose...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Med
Main Authors: Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Papassotiriou, Gerasimos-Petros, Kastritis, Efstathios, Margeli, Alexandra, Kanellias, Nikolaos, Eleutherakis-Papaiakovou, Evangelos, Migkou, Magdalini, Fotiou, Despina, Roussou, Maria, Gavriatopoulou, Maria, Malandrakis, Panagiotis, Psimenou, Erasmia, Papassotiriou, Ioannis, Dimopoulos, Meletios A.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7600599/
https://ncbi.nlm.nih.gov/pubmed/33022958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9103201
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares